Detalhe da pesquisa
1.
Genetic variation in STAT4 predicts response to interferon-α therapy for hepatitis B e antigen-positive chronic hepatitis B.
Hepatology
; 63(4): 1102-11, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26704347
2.
Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.
Hepatology
; 62(1): 118-28, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802187
3.
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Tumour Biol
; 37(7): 9931-42, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26815502
4.
miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Tumour Biol
; 37(7): 8961-72, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26753964
5.
Caspase polymorphisms and prognosis of hepatocellular carcinoma.
PLoS One
; 12(4): e0176802, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453560
6.
Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.
Sci Rep
; 5: 16278, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538132
7.
Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
Am J Cancer Res
; 5(1): 396-410, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25628948
8.
Genetic polymorphisms in apoptosis-related genes and the prognosis of hepatocellular carcinoma.
Am J Cancer Res
; 5(10): 3249-59, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26693075
9.
Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies.
PLoS One
; 8(11): e79584, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24278149
10.
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
Nat Genet
; 45(1): 72-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242368